Modality Solutions Achieves ISO 9001:2015 Recertification, Expands Certification Scope to Greenwood Laboratory
Modality Solutions has successfully achieved recertification to the ISO 9001:2015 standard, reaffirming its commitment...
read Details
Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC). Modality Solutions is proud to have been a part of its cold chain strategy!
Modality Solutions has successfully achieved recertification to the ISO 9001:2015 standard, reaffirming its commitment...
read Details
Today, four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification...
read Details
Modality Solutions is proud to announce the launch of our new Greenwood Lab—a state-of-the-art...
read Details